← Leaderboards
Ge Jin
Case Western Reserve University
$9,062,600
Attributed
$10,896,321
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2011–24$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,896,321 · 6
By mechanism
R01$10,141,853 · 4
R56$754,468 · 2
Top collaborators
- Bingcheng Wang5 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Aaron Weinberg$13,644,444
- Scott Frederick Sieg$6,670,247
- Bingcheng Wang$12,028,840
- Thomas S McCormick$4,069,015
- Scot C Remick$11,938,221
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMalignant NeoplasmsCellsImmuneEpidermal Growth Factor ReceptorMediatingSuccessT-LymphocyteIn VitroCell MotilityExtracellular VesiclesExosomePublishingTumorigenesisMolecularResponseEpithelial CellsTumor ProgressionResponse ElementsSignal TransductionMitogen-Activated Protein KinasesNovel StrategiesTransactivationOral
Grant awards (21)
(PQ1) HIV-infected T-cell exosomes in lung cancer progression$703,784
R01 · FY2024 · CA · contact PI
Role of HIV in KSHV oral transmission$656,317
R01 · FY2024 · CA · contact PI
(PQ1) HIV-infected T-cell exosomes in lung cancer progression$700,187
R01 · FY2023 · CA · contact PI
Role of HIV in KSHV oral transmission$645,047
R01 · FY2023 · CA · contact PI
(PQ1) HIV-infected T-cell exosomes in lung cancer progression$774,099
R01 · FY2022 · CA · contact PI
Role of HIV in KSHV oral transmission$610,432
R01 · FY2022 · CA · contact PI
(PQ1) HIV-infected T-cell exosomes in lung cancer progression$756,944
R01 · FY2021 · CA · contact PI
Role of HIV in KSHV oral transmission$677,802
R01 · FY2021 · CA · contact PI
Premalignant oral lesions in people living with HIV$401,218
R56 · FY2021 · DE · contact PI
Oral immune plasticity, HIV-infected T cell extracellular vesicles, and oral cancer$382,375
R01 · FY2021 · DE · contact PI
(PQ1) HIV-infected T-cell exosomes in lung cancer progression$732,429
R01 · FY2020 · CA · contact PI
Oral immune plasticity, HIV-infected T cell extracellular vesicles, and oral cancer$381,781
R01 · FY2020 · DE · contact PI
Head Neck Cancer, beta-defensins, and immune responses$396,250
R01 · FY2019 · DE · contact PI
Oral immune plasticity, HIV-infected T cell extracellular vesicles, and oral cancer$380,000
R01 · FY2019 · DE · contact PI
Head Neck Cancer, beta-defensins, and immune responses$396,250
R01 · FY2018 · DE · contact PI
Oral immune plasticity, HIV-infected T cell extracellular vesicles, and oral cancer$380,000
R01 · FY2018 · DE · contact PI
Head Neck Cancer, beta-defensins, and immune responses$396,250
R01 · FY2017 · DE · contact PI
Oral immune plasticity, HIV-infected T cell extracellular vesicles, and oral cancer$379,406
R01 · FY2017 · DE · contact PI
Head Neck Cancer, beta-defensins, and immune responses$396,250
R01 · FY2016 · DE · contact PI
Head Neck Cancer, beta-defensins, and immune responses$396,250
R01 · FY2015 · DE · contact PI
Innate Immunity and Oral Carcinogenesis$353,250
R56 · FY2011 · DE · contact PI